- Home
- Publications
- Publication Search
- Publication Details
Title
Model-based treatment optimization of a novel VEGFR inhibitor
Authors
Keywords
-
Journal
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
Volume 74, Issue 2, Pages 315-326
Publisher
Wiley
Online
2012-02-02
DOI
10.1111/j.1365-2125.2012.04197.x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Correlation between bevacizumab-related hypertension and response in mCRC patients.
- (2017) A. De Stefano et al. JOURNAL OF CLINICAL ONCOLOGY
- A retrospective evaluation of antiangiogenic therapy induced hypertension in metastatic renal cell carcinoma.
- (2017) K. L. Wilhelm et al. JOURNAL OF CLINICAL ONCOLOGY
- Association of hypertension (HTN) and clinical outcome in a phase II trial of cisplatin (C), pemetrexed (P), and bevacizumab (B) in patients (pts) with untreated malignant mesothelioma.
- (2017) S. M. Radaideh et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase I dose-escalation study of E7080, a selective tyrosine kinase inhibitor, administered orally to patients with solid tumors.
- (2017) D. S. Hong et al. JOURNAL OF CLINICAL ONCOLOGY
- Analysis of early hypertension (HTN) and clinical outcome with bevacizumab (BV).
- (2017) H. Hurwitz et al. JOURNAL OF CLINICAL ONCOLOGY
- A phase II trial of the multitargeted kinase inhibitor E7080 in advanced radioiodine (RAI)-refractory differentiated thyroid cancer (DTC).
- (2017) S. I. Sherman et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase I Dose-Escalation Study and Biomarker Analysis of E7080 in Patients with Advanced Solid Tumors
- (2011) K. Yamada et al. CLINICAL CANCER RESEARCH
- Multikinase inhibitors: a new option for the treatment of thyroid cancer
- (2011) Matti L. Gild et al. Nature Reviews Endocrinology
- Pharmacokinetic/Pharmacodynamic Modeling of Biomarker Response to Sunitinib in Healthy Volunteers
- (2010) A Lindauer et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Piraña and PCluster: A modeling environment and cluster infrastructure for NONMEM
- (2010) Ron J. Keizer et al. COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE
- 453 Population pharmacokinetics (PK) and exposure/response relationships of the receptor tyrosine kinase inhibitor E7080 in phase I studies
- (2010) A. Gupta et al. EJC SUPPLEMENTS
- A model of hypertension and proteinuria in cancer patients treated with the anti-angiogenic drug E7080
- (2010) Ron J. Keizer et al. JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS
- Blood pressure as a potential biomarker of the efficacy angiogenesis inhibitor
- (2009) B. I. Levy ANNALS OF ONCOLOGY
- Relationship between exposure to sunitinib and efficacy and tolerability endpoints in patients with cancer: results of a pharmacokinetic/pharmacodynamic meta-analysis
- (2009) Brett E. Houk et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Imatinib pharmacokinetics and its correlation with response and safety in chronic-phase chronic myeloid leukemia: a subanalysis of the IRIS study
- (2008) R. A. Larson et al. BLOOD
- Relationship of imatinib-free plasma levels and target genotype with efficacy and tolerability
- (2008) N Widmer et al. BRITISH JOURNAL OF CANCER
- Multi-Kinase Inhibitor E7080 Suppresses Lymph Node and Lung Metastases of Human Mammary Breast Tumor MDA-MB-231 via Inhibition of Vascular Endothelial Growth Factor-Receptor (VEGF-R) 2 and VEGF-R3 Kinase
- (2008) J. Matsui et al. CLINICAL CANCER RESEARCH
- Dose Selection in Phase I Studies: Why We Should Always Go for the Top
- (2008) Stefan Sleijfer et al. JOURNAL OF CLINICAL ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now